THE DEAL, AT A GLANCE
From the announcementRougeTx
01Who is involvedBacked by BioGeneration Ventures (BGV), Angelini Ventures, the EIB’s Aurea co-investment facility, Kurma PartnersFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedRougeTx raised $58M Series A, announced 2026-10-06From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersRougeTx raised a $58m Series A to advance a first-in-class HHT therapy focused on diseases driven by vascular instability.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
RougeTx · Financing Record
Explore source-linked visual explanations for RougeTx. Unsupported claims are withheld while source review continues.
Record 13510 · Recorded date: 2026-10-06
Explore company records →